NCT00463385 A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia Status COMPLETED Phase PHASE2
NCT00393380 Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor Status TERMINATED Phase PHASE2
NCT00360035 Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid Metaplasia Status COMPLETED Phase PHASE2
NCT00354120 Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant Status COMPLETED Phase PHASE2/PHASE3
NCT00309842 Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases Status COMPLETED Phase PHASE2
NCT00287261 A Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM) Status COMPLETED Phase PHASE2
NCT00255346 Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) Status COMPLETED Phase PHASE2
NCT00235391 Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload Status COMPLETED Phase PHASE3
NCT00148980 Creation of Bone Marrow Microenvironment for Treatment of Myelodysplastic Syndrome (MDS) in Conjunction With Allogeneic Stem Cell Transplantation Status WITHDRAWN Phase PHASE2
NCT00136409 A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML) Status COMPLETED Phase PHASE2
NCT00081874 RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma Status COMPLETED Phase PHASE1/PHASE2